# Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus

Study · id `cardio:ct-nct01206647` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01206647](<https://clinicaltrials.gov/study/NCT01206647>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01206647

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT01206647. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2011-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT01206647, source copy `cardio:ctgov-nct01206647-2010-09-22`, retrieved 2026-10-26)
- Start date: 2010-02 (registry gives no type) (ClinicalTrials.gov record NCT01206647, source copy `cardio:ctgov-nct01206647-2010-09-22`, retrieved 2026-10-26)
- Primary completion: 2011-02 (anticipated) (ClinicalTrials.gov record NCT01206647, source copy `cardio:ctgov-nct01206647-2010-09-22`, retrieved 2026-10-26)
- Completion: 2011-02 (anticipated) (ClinicalTrials.gov record NCT01206647, source copy `cardio:ctgov-nct01206647-2010-09-22`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT01206647, source copy `cardio:ctgov-nct01206647-2010-09-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01206647-2010-09-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Metformin and Saxagliptin
- Lead sponsor: ikfe-CRO GmbH
- Lead sponsor class: INDUSTRY
- Collaborator: AstraZeneca
- Collaborator class: INDUSTRY
- Collaborator: IKFE Institute for Clinical Research and Development
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: AstraZeneca (`cardio:astrazeneca`)

## Provenance

Content hash: 9681dba6c2ca75f761f2eb59bf4e7e585abeb87228768b0317328bcce1ff6cbd
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
